Xenglu 10mg Tablet 14s – SGLT2 Inhibitor for Better Blood Sugar & Heart Protection
Xenglu 10mg Tablet 14s – SGLT2 Inhibitor for Better Blood Sugar & Heart Protection
Xenglu 10mg Tablet 14s – SGLT2 Inhibitor for Better Blood Sugar & Heart Protection
Description
Xenglu 10mg Tablet 14s – Empagliflozin 10mg for Type 2 Diabetes & Cardiovascular Protection
Xenglu 10mg Tablet contains empagliflozin 10mg, a highly effective SGLT2 inhibitor that lowers blood glucose by helping the kidneys remove excess sugar through urine. Beyond excellent sugar control, it is clinically proven to reduce the risk of heart failure hospitalisation, slow kidney disease progression, and lower cardiovascular death risk in type 2 diabetes patients with heart disease. Taken just once daily, this 14-tablet pack offers convenient 2-week therapy with additional benefits of modest weight loss and blood pressure reduction.
